EMEA-001523-PIP02-14-M02
Key facts
| Invented name |
Tremfya
|
| Active substance |
Guselkumab
|
| Therapeutic area |
Immunology-Rheumatology-Transplantation
|
| Decision number |
P/0129/2018
|
| PIP number |
EMEA-001523-PIP02-14-M02
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
Treatment of psoriasis
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
Janssen Cilag International NV
Tel. +3214602111 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|